Insmed Inc
INSM
ISIN null / Valor 12614415
Insmed Inc
UMushroom community rating:
About company
Insmed Incorporated is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare and severe diseases, particularly targeting pulmonary conditions. The company's portfolio includes inhaled pharmaceuticals designed to treat various lung diseases, and it has expanded its pipeline through strategic acquisitions, such as Celtrix Pharmaceuticals, and partnerships like a worldwide license agreement with AstraZeneca. Following its transition to a public company, Insmed continues to advance clinical programs across its four strategic pillars, aiming to deliver meaningful clinical data and address unmet medical needs in the rare disease sector. Headquartered in Bridgewater, New Jersey, Insmed leverages its expertise and collaborative efforts to drive growth and enhance its position in the specialized pharmaceutical market.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
23062 M
Market cap (USD)
3,094,621
Daily traded volume (Shares)
69.6 / 67.75
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
